DBV Technologies (DBVT) Non-Current Debt (2015 - 2019)
DBV Technologies (DBVT) reported Non-Current Debt of $798066.0 for Q4 2019, down 45.29% year-over-year from $1.5 million in Q4 2018, and down 45.29% quarter-over-quarter from $1.5 million in Q4 2018.
DBV Technologies (DBVT) Non-Current Debt (2015 - 2019) Analysis & Trends
DBV Technologies (DBVT) has 5 years of Non-Current Debt data on file, last reported at $798066.0 in Q4 2019.
- Non-Current Debt for Q4 2019 came in at $798066.0, down 45.29% year-over-year; the trailing twelve-month figure through Dec 2019 was $798066.0 (down 45.29% YoY), and the FY2019 annual result was $798066.0, down 45.29% from the prior year.
- Non-Current Debt declined to $798066.0 in Q4 2019 per DBVT's latest filing, from $1.5 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $5.1 million in Q4 2015 and troughed at $798066.0 in Q4 2019.
- A 5-year average of $2.8 million and a median of $2.1 million in 2017 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2016 and 2017: Non-Current Debt decreased 15.01% in 2016, then tumbled 50.85% in 2017.
- A 5-year view of Non-Current Debt shows it stood at $5.1 million in 2015, then retreated by 15.01% to $4.4 million in 2016, then plunged by 50.85% to $2.1 million in 2017, then plunged by 32.12% to $1.5 million in 2018, then slumped by 45.29% to $798066.0 in 2019.
- Business Quant data shows DBVT's Non-Current Debt at $798066.0 in Q4 2019, $1.5 million in Q4 2018, and $2.1 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 798,066.01 |
| Dec 31, 2019 | 798,066.01 |
| Dec 31, 2018 | 1.46 Mn |
| Dec 31, 2018 | 1.46 Mn |
| Dec 31, 2017 | 2.15 Mn |
| Dec 31, 2017 | 2.15 Mn |
| Dec 31, 2016 | 4.37 Mn |
| Dec 31, 2016 | 4.37 Mn |
| Dec 31, 2015 | 5.14 Mn |
| Dec 31, 2015 | 5.14 Mn |